— Know what they know.
Not Investment Advice

LDXHF OTC

Lumos Diagnostics Holdings Ltd.
1W: -11.9% 1M: -15.5% 3M: -12.5% YTD: -65.7% 1Y: -39.1% 3Y: -5.4% 5Y: -90.3%
$0.07
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Specialties · Tech Score Sell · Power 40 · $66.1M mcap · 573M float · 0.0049% daily turnover · Short 39% of daily vol

Balance Sheet Trends

Total Assets
$41M +95.5% ▲
5Y CAGR: -16.1%
Total Liabilities
$18M +21.9% ▲
5Y CAGR: -14.8%
Shareholders Equity
$23M +270.8% ▲
5Y CAGR: -17.1%
Cash & Investments
$15M +687.7% ▲
5Y CAGR: -19.3%
Total Debt
$6M -15.1% ▼
5Y CAGR: -5.7%
Net Debt
-$9M -288.4% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$8M$3M$6M$2M$15M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$8M$3M$6M$2M$15M
Net Receivables$2M$890K$2M$1M$2M
Inventory$3M$1M$784K$521K$2M
Other Current Assets$0$599K$109K$2M$517K
Total Current Assets$13M$6M$10M$6M$20M
Property, Plant & Equip.$11M$9M$8M$6M$7M
Goodwill & Intangibles$13M$4M$10M$8M$13M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$7M$18K$0$0
Total Non-Current Assets$23M$19M$17M$14M$21M
Total Assets$37M$25M$27M$21M$41M
— Liabilities —
Accounts Payable$1M$1M$546K$1M$2M
Short-Term Debt$971K$1M$952K$0$1M
Deferred Revenue$7M$0$0$0$7M
Other Current Liabilities$2M$3M$8M$5M$954K
Total Current Liabilities$13M$8M$13M$9M$13M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$6M$8M$7M$6M$5M
Total Liabilities$19M$16M$20M$15M$18M
— Equity —
Common Stock$92M$92M$98M$104M$123M
Retained Earnings-$75M-$82M-$91M-$98M-$103M
Accumulated OCI$280K-$678K-$259K$35K$2M
Total Stockholders Equity$18M$9M$7M$6M$23M
Total Liabilities & Equity$37M$25M$27M$21M$41M
— Key Metrics —
Total Debt$7M$10M$8M$7M$6M
Net Debt-$784K$7M$2M$5M-$9M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms